Clinical Trial Update: Boston Scientific Post Market Subcutaneous-Implantable Cardioverter Defibrillator (S-ICD) Registry

View source ↗

Summary

Boston Scientific's post-market registry for the subcutaneous implantable cardioverter-defibrillator has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Tachycardia, Ventricular | Status: COMPLETED | Results posted: 2023-11-07